Nordic Capital to acquire BWXT's nuclear medicine business for $800 million

Type: Acquisition · Technology: Nuclear · Country: United States · Value: $800M · Announced: 2026-08-07

Nordic Capital has agreed to acquire BWXT's nuclear medicine business for $800 million. This transaction involves the take-private of BWXT's nuclear medicine operations. The deal is driven by technological advancements in the sector. Nordic Capital is a private equity firm focused on the Nordic region.